Kymera Therapeutics, Inc.
KYMR · Biological Products, (No Diagnostic Substances) · 82.3M shares · +50%/yr ↑ dilution · EDGAR filings ↗
Reference price $113.70 · est. market cap ~$9.4B — last insider sale, 2026-06-25 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — targeted-protein-degradation clinical, heavy burn ($234M), very well-funded.
Strengths
- Liquidity — current ratio 10.5 (85th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Net lossNet loss (net margin -794.0%)
- Cash burnNegative free cash flow (-234.3M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Chronic dilutionShare count +50%/yr over 3y (dilution, book value/share -4%)
- Strong balance sheetStrong balance sheet — $1.6B cash & investments, ~28 quarters of runway
- Notable holderHeld by 4 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +1 more (as of 2026-03-31)
- Trial resultTrial topline data reported — see 8-K for outcome 8-K ↗
- Insider sellingInsider selling — 167 open-market sale(s) by 8 insider(s) (cluster of 8 insiders, ~$165M, last 6mo) Form 4 ↗
- Revenue declineRevenue -16.7% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
0.0%
Operating margin
-891.1%
Net margin
-794.0%
Return on equity
-19.7%
Return on assets
-17.9%
Revenue growth (QoQ)
-16.7%
Current ratio
10.5×
Free cash flow
-$234M
EBITDA
-$341M
Tangible book value
$1.6B
Cash & investments
$1.6B
Cash runway
28q
Stock comp / revenue
152.8%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-25 | Goodman Noah | Sell | 2.5K | $119.00 |
| 2026-06-25 | Booth Bruce | Sell | 11K | $123.62 |
| 2026-06-25 | Booth Bruce | Sell | 10K | $113.70 |
| 2026-06-25 | Booth Bruce | Sell | 112K | $120.66 |
| 2026-06-25 | Booth Bruce | Sell | 41K | $121.38 |
| 2026-06-25 | Booth Bruce | Sell | 37K | $119.71 |
| 2026-06-25 | Booth Bruce | Sell | 12K | $124.61 |
| 2026-06-25 | Booth Bruce | Sell | 3.7K | $125.82 |
| 2026-06-25 | Booth Bruce | Sell | 1.6K | $126.71 |
| 2026-06-25 | Booth Bruce | Sell | 25K | $127.37 |
| 2026-06-25 | Booth Bruce | Sell | 2.2K | $128.69 |
| 2026-06-25 | Booth Bruce | Sell | 337 | $129.61 |
| 2026-06-25 | Booth Bruce | Sell | 5.1K | $119.71 |
| 2026-06-25 | Booth Bruce | Sell | 16K | $120.66 |
| 2026-06-25 | Booth Bruce | Sell | 5.7K | $121.38 |
| 2026-06-25 | Booth Bruce | Sell | 698 | $122.67 |
| 2026-06-25 | Booth Bruce | Sell | 1.5K | $123.62 |
| 2026-06-25 | Booth Bruce | Sell | 1.6K | $124.61 |
| 2026-06-25 | Booth Bruce | Sell | 522 | $125.82 |
| 2026-06-25 | Booth Bruce | Sell | 223 | $126.71 |
| 2026-06-25 | Booth Bruce | Sell | 3.5K | $127.37 |
| 2026-06-25 | Booth Bruce | Sell | 305 | $128.69 |
| 2026-06-25 | Booth Bruce | Sell | 46 | $129.61 |
| 2026-06-25 | Booth Bruce | Sell | 11K | $116.53 |
| 2026-06-25 | Booth Bruce | Sell | 3.4K | $117.50 |
| 2026-06-25 | Booth Bruce | Sell | 2.6K | $118.60 |
| 2026-06-25 | Goodman Noah | Option exercise | 5.0K | $21.05 |
| 2026-06-25 | Goodman Noah | Sell | 2.5K | $109.00 |
| 2026-06-25 | Booth Bruce | Sell | 5.0K | $122.67 |
| 2026-06-25 | Booth Bruce | Sell | 10.0K | $107.30 |
| 2026-06-25 | Booth Bruce | Sell | 159 | $108.02 |
| 2026-06-25 | Booth Bruce | Sell | 14K | $108.83 |
| 2026-06-25 | Booth Bruce | Sell | 1.9K | $110.30 |
| 2026-06-25 | Booth Bruce | Sell | 614 | $110.79 |
| 2026-06-25 | Booth Bruce | Sell | 719 | $111.89 |
| 2026-06-25 | Booth Bruce | Sell | 9.2K | $114.65 |
| 2026-06-25 | Booth Bruce | Sell | 58K | $115.57 |
| 2026-06-25 | Booth Bruce | Sell | 82K | $116.53 |
| 2026-06-25 | Booth Bruce | Sell | 24K | $117.50 |
| 2026-06-25 | Booth Bruce | Sell | 19K | $118.60 |
| 2026-06-25 | Booth Bruce | Sell | 1.4K | $107.30 |
| 2026-06-25 | Booth Bruce | Sell | 23 | $108.02 |
| 2026-06-25 | Booth Bruce | Sell | 2.0K | $108.83 |
| 2026-06-25 | Booth Bruce | Sell | 265 | $110.30 |
| 2026-06-25 | Booth Bruce | Sell | 86 | $110.79 |
| 2026-06-25 | Booth Bruce | Sell | 100 | $111.89 |
| 2026-06-25 | Booth Bruce | Sell | 1.4K | $113.70 |
| 2026-06-25 | Booth Bruce | Sell | 1.3K | $114.65 |
| 2026-06-25 | Booth Bruce | Sell | 8.4K | $115.57 |
| 2026-06-24 | Booth Bruce | Sell | 104K | $100.42 |
| 2026-06-24 | Booth Bruce | Sell | 15K | $100.42 |
| 2026-06-24 | Booth Bruce | Sell | 14K | $101.14 |
| 2026-06-24 | Booth Bruce | Sell | 2.0K | $101.14 |
| 2026-06-23 | Booth Bruce | Sell | 1.2K | $99.98 |
| 2026-06-23 | Booth Bruce | Sell | 173 | $99.98 |
| 2026-06-22 | Goodman Noah | Sell | 2.5K | $99.00 |
| 2026-06-22 | Booth Bruce | Sell | 18K | $103.42 |
| 2026-06-22 | Booth Bruce | Sell | 9.6K | $104.38 |
| 2026-06-22 | Booth Bruce | Sell | 2.6K | $103.42 |
| 2026-06-22 | Booth Bruce | Sell | 1.3K | $104.38 |
| 2026-06-22 | Booth Bruce | Sell | 15K | $92.14 |
| 2026-06-22 | Booth Bruce | Sell | 2.0K | $94.48 |
| 2026-06-22 | Booth Bruce | Sell | 12K | $95.12 |
| 2026-06-22 | Booth Bruce | Sell | 21K | $96.24 |
| 2026-06-22 | Booth Bruce | Sell | 16K | $97.68 |
| 2026-06-22 | Booth Bruce | Sell | 26K | $98.58 |
| 2026-06-22 | Booth Bruce | Sell | 52K | $99.57 |
| 2026-06-22 | Booth Bruce | Sell | 56K | $100.17 |
| 2026-06-22 | Booth Bruce | Sell | 6.6K | $101.61 |
| 2026-06-22 | Booth Bruce | Sell | 9.0K | $102.48 |
| 2026-06-22 | Booth Bruce | Sell | 2.2K | $92.14 |
| 2026-06-22 | Booth Bruce | Sell | 286 | $94.48 |
| 2026-06-22 | Booth Bruce | Sell | 1.6K | $95.12 |
| 2026-06-22 | Booth Bruce | Sell | 2.9K | $96.24 |
| 2026-06-22 | Booth Bruce | Sell | 2.2K | $97.68 |
| 2026-06-22 | Booth Bruce | Sell | 3.6K | $98.58 |
| 2026-06-22 | Booth Bruce | Sell | 7.3K | $99.57 |
| 2026-06-22 | Booth Bruce | Sell | 7.9K | $100.17 |
| 2026-06-22 | Booth Bruce | Sell | 918 | $101.61 |
| 2026-06-22 | Booth Bruce | Sell | 1.3K | $102.48 |
| 2026-06-22 | Goodman Noah | Option exercise | 2.5K | $21.05 |
| 2026-06-18 | Booth Bruce | Sell | 5.7K | $92.16 |
| 2026-06-18 | Booth Bruce | Sell | 793 | $92.16 |
| 2026-06-18 | Booth Bruce | Sell | 4.5K | $91.85 |
| 2026-06-18 | Booth Bruce | Sell | 8.8K | $90.48 |
| 2026-06-18 | Booth Bruce | Sell | 32K | $91.85 |
| 2026-06-18 | Booth Bruce | Sell | 63K | $90.48 |
| 2026-06-17 | Booth Bruce | Sell | 92K | $90.38 |
| 2026-06-17 | Booth Bruce | Option exercise | 12K | $20.00 |
| 2026-06-17 | Booth Bruce | Sell | 13K | $90.38 |
| 2026-06-17 | Booth Bruce | Sell | 12K | $89.98 |
| 2026-06-02 | Jacobs Bruce N. | Option exercise | 13K | $2.08 |
| 2026-05-27 | Chadwick Jeremy G | Sell | 3.7K | $81.50 |
| 2026-05-27 | Chadwick Jeremy G | Sell | 600 | $82.08 |
| 2026-05-26 | Chadwick Jeremy G | Sell | 3.7K | $78.36 |
| 2026-05-26 | Chadwick Jeremy G | Sell | 324 | $79.17 |
| 2026-05-26 | Chadwick Jeremy G | Sell | 3.8K | $79.39 |
| 2026-05-26 | Chadwick Jeremy G | Sell | 4.5K | $80.02 |
| 2026-05-26 | Chadwick Jeremy G | Sell | 551 | $80.71 |
| 2026-05-19 | Esposito Pamela | Option exercise | 1.0K | $31.20 |
| 2026-05-18 | Jacobs Bruce N. | Option exercise | 15K | $2.08 |
| 2026-05-11 | Ridloff Elena | Option exercise | 3.0K | $31.20 |
| 2026-05-11 | Ridloff Elena | Sell | 3.0K | $87.00 |
| 2026-04-29 | Mainolfi Nello | Sell | 17K | $80.74 |
| 2026-04-29 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2026-04-29 | Mainolfi Nello | Sell | 12K | $81.70 |
| 2026-04-29 | Mainolfi Nello | Sell | 936 | $82.45 |
| 2026-04-22 | Booth Bruce | Option exercise | 5.6K | $14.18 |
| 2026-04-22 | Booth Bruce | Option exercise | 259 | $20.00 |
| 2026-04-22 | Booth Bruce | Sell | 5.9K | $89.96 |
| 2026-04-22 | Booth Bruce | Sell | 88 | $90.08 |
| 2026-04-22 | Booth Bruce | Sell | 12 | $90.08 |
| 2026-04-22 | Chadwick Jeremy G | Option exercise | 100 | $30.17 |
| 2026-04-22 | Chadwick Jeremy G | Option exercise | 200 | $43.50 |
| 2026-04-22 | Chadwick Jeremy G | Sell | 300 | $90.00 |
| 2026-04-15 | Booth Bruce | Option exercise | 2.2K | $14.18 |
| 2026-04-15 | Booth Bruce | Sell | 2.2K | $89.95 |
| 2026-04-15 | Booth Bruce | Sell | 2.8K | $90.10 |
| 2026-04-15 | Booth Bruce | Sell | 385 | $90.10 |
| 2026-04-15 | Chadwick Jeremy G | Option exercise | 1.3K | $43.50 |
| 2026-04-15 | Chadwick Jeremy G | Sell | 1.3K | $90.00 |
| 2026-04-14 | Goodman Noah | Sell | 1.3K | $90.00 |
| 2026-04-14 | Chadwick Jeremy G | Option exercise | 4.5K | $30.17 |
| 2026-04-14 | Booth Bruce | Sell | 4.2K | $89.97 |
| 2026-04-14 | Booth Bruce | Option exercise | 4.2K | $14.18 |
| 2026-04-14 | Chadwick Jeremy G | Option exercise | 785 | $43.50 |
| 2026-04-14 | Chadwick Jeremy G | Sell | 5.3K | $90.00 |
| 2026-04-10 | Goodman Noah | Sell | 2.0K | $87.35 |
| 2026-04-09 | Goodman Noah | Option exercise | 2.5K | $21.05 |
| 2026-04-09 | Goodman Noah | Sell | 3.1K | $86.62 |
| 2026-04-09 | Goodman Noah | Sell | 2.7K | $87.11 |
| 2026-04-09 | Goodman Noah | Sell | 2.5K | $89.00 |
| 2026-04-01 | Chadwick Jeremy G | Sell | 14K | $85.41 |
| 2026-04-01 | Chadwick Jeremy G | Option exercise | 15K | $29.64 |
| 2026-04-01 | Ridloff Elena | Sell | 3.4K | $85.19 |
| 2026-04-01 | Ridloff Elena | Option exercise | 4.6K | $14.18 |
| 2026-04-01 | Ridloff Elena | Sell | 1.2K | $86.05 |
| 2026-04-01 | Chadwick Jeremy G | Sell | 1.1K | $86.05 |
| 2026-03-31 | Ridloff Elena | Sell | 7.4K | $85.37 |
| 2026-03-31 | Chadwick Jeremy G | Sell | 7.6K | $85.38 |
| 2026-03-31 | Chadwick Jeremy G | Option exercise | 7.6K | $29.64 |
| 2026-03-31 | Ridloff Elena | Option exercise | 7.4K | $14.18 |
| 2026-03-25 | Chadwick Jeremy G | Option exercise | 25K | $29.64 |
| 2026-03-25 | Chadwick Jeremy G | Sell | 25K | $80.26 |
| 2026-03-23 | Chadwick Jeremy G | Sell | 1.2K | $80.05 |
| 2026-03-23 | Chadwick Jeremy G | Option exercise | 84K | $29.64 |
| 2026-03-23 | Chadwick Jeremy G | Sell | 23K | $76.73 |
| 2026-03-23 | Chadwick Jeremy G | Sell | 53K | $77.21 |
| 2026-03-23 | Chadwick Jeremy G | Sell | 8.2K | $78.40 |
| 2026-03-23 | Chadwick Jeremy G | Sell | 6.1K | $79.87 |
| 2026-03-20 | Esposito Pamela | Option exercise | 2.5K | $49.10 |
| 2026-03-20 | Esposito Pamela | Sell | 700 | $77.71 |
| 2026-03-20 | Esposito Pamela | Sell | 600 | $79.24 |
| 2026-03-20 | Esposito Pamela | Sell | 1.2K | $79.94 |
| 2026-03-11 | Chadwick Jeremy G | Option exercise | 20K | $43.50 |
| 2026-03-11 | Chadwick Jeremy G | Sell | 1.8K | $82.13 |
| 2026-03-11 | Chadwick Jeremy G | Sell | 13K | $83.10 |
| 2026-03-11 | Chadwick Jeremy G | Sell | 11K | $83.72 |
| 2026-03-04 | Chadwick Jeremy G | Sell | 2.0K | $85.04 |
| 2026-03-04 | Chadwick Jeremy G | Sell | 394 | $84.00 |
| 2026-03-04 | Chadwick Jeremy G | Sell | 1.1K | $85.78 |
| 2026-03-04 | Chadwick Jeremy G | Sell | 358 | $86.62 |
| 2026-03-04 | Gollob Jared | Sell | 492 | $84.00 |
| 2026-03-04 | Gollob Jared | Sell | 2.5K | $85.04 |
| 2026-03-04 | Gollob Jared | Sell | 1.4K | $85.78 |
| 2026-03-04 | Gollob Jared | Sell | 447 | $86.62 |
| 2026-03-04 | Jacobs Bruce N. | Sell | 492 | $84.00 |
| 2026-03-04 | Jacobs Bruce N. | Sell | 2.5K | $85.04 |
| 2026-03-04 | Jacobs Bruce N. | Sell | 1.4K | $85.78 |
| 2026-03-04 | Jacobs Bruce N. | Sell | 447 | $86.62 |
| 2026-03-02 | Gollob Jared | Grant | 18K | — |
| 2026-03-02 | Gollob Jared | Sell | 1.5K | $87.75 |
| 2026-03-02 | Gollob Jared | Sell | 1.1K | $88.50 |
| 2026-03-02 | Gollob Jared | Sell | 3.0K | $89.66 |
| 2026-03-02 | Jacobs Bruce N. | Grant | 18K | — |
| 2026-03-02 | Jacobs Bruce N. | Sell | 2.0K | $87.75 |
| 2026-03-02 | Jacobs Bruce N. | Sell | 1.4K | $88.50 |
| 2026-03-02 | Jacobs Bruce N. | Sell | 4.1K | $89.66 |
| 2026-03-02 | Booth Bruce | Sell | 10K | $90.13 |
| 2026-03-02 | Adams Brian | Grant | 4.1K | — |
| 2026-03-02 | Chadwick Jeremy G | Grant | 13K | — |
| 2026-03-02 | Chadwick Jeremy G | Sell | 549 | $87.75 |
| 2026-03-02 | Chadwick Jeremy G | Sell | 383 | $88.50 |
| 2026-03-02 | Chadwick Jeremy G | Sell | 1.1K | $89.66 |
| 2026-03-02 | Booth Bruce | Sell | 72K | $90.13 |
| 2026-03-02 | Goodman Noah | Grant | 9.2K | — |
| 2026-02-25 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2026-02-25 | Mainolfi Nello | Sell | 20K | $89.78 |
| 2026-02-25 | Mainolfi Nello | Sell | 5.4K | $90.39 |
| 2026-02-25 | Mainolfi Nello | Sell | 3.3K | $91.76 |
| 2026-02-25 | Mainolfi Nello | Sell | 1.5K | $92.81 |
| 2026-02-25 | Mainolfi Nello | Sell | 8 | $93.49 |
| 2026-02-20 | Esposito Pamela | Option exercise | 2.5K | $49.10 |
| 2026-02-20 | Esposito Pamela | Sell | 1.9K | $87.06 |
| 2026-02-20 | Esposito Pamela | Sell | 600 | $88.10 |
| 2026-01-20 | Esposito Pamela | Option exercise | 3.0K | $31.20 |
| 2026-01-20 | Esposito Pamela | Option exercise | 2.5K | $49.10 |
| 2026-01-20 | Esposito Pamela | Sell | 400 | $66.68 |
| 2026-01-20 | Esposito Pamela | Sell | 4.9K | $67.99 |
| 2026-01-20 | Esposito Pamela | Sell | 200 | $68.52 |
| 2026-01-05 | Mainolfi Nello | Option exercise | 3.1K | $32.07 |
| 2025-12-31 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2025-12-31 | Mainolfi Nello | Sell | 24K | $77.95 |
| 2025-12-31 | Mainolfi Nello | Sell | 6.0K | $78.52 |
| 2025-12-17 | Esposito Pamela | Option exercise | 3.0K | $31.20 |
| 2025-12-17 | Esposito Pamela | Sell | 8.0K | $82.34 |
| 2025-12-17 | Esposito Pamela | Option exercise | 12K | $27.67 |
| 2025-12-17 | Esposito Pamela | Sell | 15K | $81.56 |
| 2025-12-17 | Esposito Pamela | Option exercise | 13K | $49.10 |
| 2025-12-17 | Mainolfi Nello | Option exercise | 2.6K | $38.53 |
| 2025-12-17 | Esposito Pamela | Sell | 4.1K | $83.45 |
| 2025-12-17 | Esposito Pamela | Sell | 1.0K | $84.07 |
| 2025-12-12 | Booth Bruce | Sell | 108 | $91.04 |
| 2025-12-12 | Booth Bruce | Sell | 570 | $91.04 |
| 2025-12-11 | Booth Bruce | Sell | 5.1K | $91.23 |
| 2025-12-11 | Booth Bruce | Sell | 976 | $91.23 |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Buy | 167K | $86.00 |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Buy | 1.8M | $86.00 |
| 2025-12-10 | Booth Bruce | Sell | 2.0K | $90.14 |
| 2025-12-10 | Booth Bruce | Sell | 3.4K | $89.25 |
| 2025-12-10 | Booth Bruce | Sell | 9.1K | $92.41 |
| 2025-12-10 | Booth Bruce | Sell | 16K | $93.20 |
| 2025-12-10 | Booth Bruce | Sell | 11K | $90.14 |
| 2025-12-10 | Booth Bruce | Sell | 6.0K | $88.64 |
| 2025-12-10 | Booth Bruce | Sell | 18K | $89.25 |
| 2025-12-10 | Booth Bruce | Sell | 31K | $88.64 |
| 2025-12-10 | Booth Bruce | Sell | 86K | $93.20 |
| 2025-12-10 | Booth Bruce | Sell | 47K | $92.41 |
| 2025-12-08 | Albers Jeffrey W. | Option exercise | 5.0K | $14.18 |
| 2025-12-08 | Albers Jeffrey W. | Sell | 2.7K | $89.32 |
| 2025-12-08 | Albers Jeffrey W. | Sell | 2.3K | $90.30 |
| 2025-12-08 | Mainolfi Nello | Option exercise | 100K | $2.08 |
| 2025-12-08 | Mainolfi Nello | Sell | 100K | $89.17 |
| 2025-12-08 | Gollob Jared | Option exercise | 49K | $5.33 |
| 2025-12-08 | Gollob Jared | Sell | 14K | $87.37 |
| 2025-12-08 | Gollob Jared | Sell | 18K | $88.02 |
| 2025-12-08 | Gollob Jared | Sell | 3.9K | $89.43 |
| 2025-12-08 | Gollob Jared | Sell | 8.6K | $90.12 |
| 2025-12-08 | Gollob Jared | Sell | 3.3K | $91.46 |
| 2025-12-08 | Gollob Jared | Sell | 1.4K | $92.19 |
| 2025-10-29 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2025-10-29 | Mainolfi Nello | Sell | 1.9K | $59.72 |
| 2025-10-29 | Mainolfi Nello | Sell | 25K | $61.02 |
| 2025-10-29 | Mainolfi Nello | Sell | 3.6K | $61.46 |
| 2025-10-15 | Gollob Jared | Option exercise | 29K | $1.31 |
| 2025-10-15 | Gollob Jared | Option exercise | 22K | $2.08 |
| 2025-10-15 | Gollob Jared | Sell | 29K | $60.37 |
| 2025-10-15 | Gollob Jared | Sell | 9.0K | $61.49 |
| 2025-10-15 | Gollob Jared | Sell | 15K | $62.72 |
| 2025-10-15 | Gollob Jared | Sell | 6.5K | $63.09 |
| 2025-10-13 | Gollob Jared | Option exercise | 800 | $1.31 |
| 2025-10-13 | Gollob Jared | Option exercise | 673 | $2.08 |
| 2025-10-13 | Gollob Jared | Sell | 3.1K | $60.00 |
| 2025-10-13 | Albers Jeffrey W. | Option exercise | 5.0K | $10.34 |
| 2025-10-13 | Albers Jeffrey W. | Sell | 5.0K | $59.19 |
| 2025-09-17 | Jacobs Bruce N. | Sell | 79K | $50.00 |
| 2025-09-17 | Jacobs Bruce N. | Option exercise | 79K | $2.08 |
| 2025-09-16 | Mainolfi Nello | Sell | 30K | $49.00 |
| 2025-09-16 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2025-09-03 | Adams Brian | Grant | 52K | — |
| 2025-06-30 | BVF PARTNERS L P/IL | Buy | 59K | $44.00 |
| 2025-06-30 | BAKER BROS. ADVISORS LP | Buy | 600K | $44.00 |
| 2025-06-30 | BAKER BROS. ADVISORS LP | Buy | 55K | $44.00 |
| 2025-06-30 | BVF PARTNERS L P/IL | Buy | 143K | $44.00 |
| 2025-06-30 | BVF PARTNERS L P/IL | Buy | 116K | $44.00 |
| 2025-06-11 | Ridloff Elena | Option exercise | 4.5K | $20.29 |
| 2025-06-11 | Ridloff Elena | Sell | 4.5K | $50.00 |
| 2025-06-03 | Albers Jeffrey W. | Sell | 6.3K | $49.00 |
| 2025-06-03 | Esposito Pamela | Option exercise | 5.0K | $29.55 |
| 2025-06-03 | Esposito Pamela | Sell | 5.0K | $49.04 |
| 2025-06-03 | Ridloff Elena | Option exercise | 12K | $27.67 |
| 2025-06-03 | Ridloff Elena | Sell | 7.2K | $45.50 |
| 2025-06-03 | Ridloff Elena | Sell | 4.8K | $47.00 |
| 2025-06-03 | Mainolfi Nello | Option exercise | 30K | $2.08 |
| 2025-06-03 | Mainolfi Nello | Sell | 30K | $49.00 |
| 2025-06-03 | Albers Jeffrey W. | Option exercise | 6.3K | $10.34 |
| 2025-05-23 | Chadwick Jeremy G | Sell | 2.6K | $29.30 |
| 2025-04-08 | Goodman Noah | Grant | 50K | — |
| 2025-03-31 | Jacobs Bruce N. | Option exercise | 25K | $2.08 |
| 2025-03-03 | Chiniara Ellen | Sell | 408 | $31.00 |
| 2025-03-03 | Chadwick Jeremy G | Grant | 25K | — |
| 2025-03-03 | Chadwick Jeremy G | Sell | 1.1K | $30.33 |
| 2025-03-03 | Chadwick Jeremy G | Sell | 252 | $31.00 |
| 2025-03-03 | Jacobs Bruce N. | Sell | 5.8K | $30.33 |
| 2025-03-03 | Jacobs Bruce N. | Sell | 1.3K | $31.00 |
| 2025-03-03 | Gollob Jared | Grant | 30K | — |
| 2025-03-03 | Gollob Jared | Sell | 4.7K | $30.33 |
| 2025-03-03 | Gollob Jared | Sell | 1.0K | $31.00 |
| 2025-03-03 | Jacobs Bruce N. | Grant | 30K | — |
| 2025-03-03 | Chiniara Ellen | Grant | 28K | — |
| 2025-03-03 | Chiniara Ellen | Sell | 1.8K | $30.33 |
| 2025-01-10 | Jacobs Bruce N. | Option exercise | 10K | $2.08 |
| 2025-01-10 | Mainolfi Nello | Option exercise | 10K | $2.08 |
| 2025-01-06 | Chiniara Ellen | Sell | 3.1K | $41.75 |
All non-derivative Form 4 activity (SEC), newest first.
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07323654 ↗ | A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma Eosinophilic Asthma | PHASE2 | Recruiting | 2027-12-01 |
| NCT07217015 ↗ | A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | PHASE2 | Recruiting | 2027-06-01 |
| NCT07412288 ↗ | First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants Healthy Participants | PHASE1 | Recruiting | 2026-12-01 |
| NCT06945458 ↗ | Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD) Atopic Dermatitis | PHASE1 | Completed | 2025-11-10 |
| NCT06673667 ↗ | First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants Healthy Participants Study | PHASE1 | Completed | 2025-04-23 |
| NCT05225584 ↗ | Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL) | PHASE1 | Completed | 2025-03-03 |
| NCT05775406 ↗ | Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors Myeloid Malignancies, Acute Lymphocytic Leukemia | PHASE1 | Completed | 2024-12-18 |
| NCT05233033 ↗ | Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | PHASE1 | Completed | 2023-07-28 |
| NCT04772885 ↗ | A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS) Healthy Volunteer, Atopic Dermatitis | PHASE1 | Completed | 2022-10-20 |
| NCT04440410 ↗ | Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis Hidradenitis Suppurativa, Dermatitis, Atopic | — | Completed | 2021-03-24 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-25 | Reg FDOtherExhibits | filing ↗ |
| 2026-06-24 | Shareholder vote | filing ↗ |
| 2026-06-08 | Exec/director change | filing ↗ |
| 2026-04-30 | ResultsExhibits | filing ↗ |
| 2026-03-27 | 5.03Exhibits | filing ↗ |
| 2026-02-26 | Material agreement1.02OtherExhibits | filing ↗ |
| 2026-02-26 | ResultsExhibits | filing ↗ |
| 2026-01-13 | ResultsReg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-25 | 0001193125-26-281817 ↗ |
| 8-K | 2026-06-24 | 2026-06-24 | 0001193125-26-281051 ↗ |
| 8-K | 2026-06-08 | 2026-06-05 | 0001193125-26-261698 ↗ |
| 8-K | 2026-04-30 | 2026-04-30 | 0001193125-26-193957 ↗ |
| 10-Q | 2026-04-30 | 2026-03-31 | 0001193125-26-193967 ↗ |
| 8-K | 2026-03-27 | 2026-03-25 | 0001193125-26-129170 ↗ |
| 8-K | 2026-02-26 | 2026-02-26 | 0001193125-26-073561 ↗ |
| 10-K | 2026-02-26 | 2025-12-31 | 0001193125-26-073395 ↗ |
| 8-K | 2026-02-26 | 2026-02-26 | 0001193125-26-073386 ↗ |
| 8-K | 2026-01-13 | 2026-01-13 | 0001193125-26-011104 ↗ |
| 8-K | 2025-12-10 | 2025-12-08 | 0001193125-25-314422 ↗ |
| 8-K | 2025-12-08 | 2025-12-08 | 0001193125-25-310670 ↗ |